Variable | n = 113 |
---|---|
 Age (years) | 68 ± 16 |
 Male sex | 65 (57.5) |
 BMI (kg/m2) | 26.1 ± 5.4 |
 Dialysis vintage (months) | 22.5 [10.3; 49.8] |
ΔMAP (mmHg) | 0.17 ± 15.5 |
 MAP pre-dialysis (mmHg) | 89.7 ± 15.3 |
 MAP post-dialysis (mmHg) | 89.3 ± 17.8 |
Aetiology of CKD | Â |
 Glomerulonephritis | 19 (16.8) |
 Hematologic malignancies | 5 (4.4) |
 Interstitial nephritis | 13 (11.5) |
 Diabetic nephropathy | 30 (26.5) |
 Hypertension, angiosclerosis or unknown | 40 (35.4) |
 ADPKD | 6 (5.4) |
Comorbidities | |
 Diabetes | 52 (46.0) |
 CVD | 84 (74.3) |
 Neuropathy | 32 (28.3) |
 Retinopathy | 36 (31.9) |
 Respiratory complications | 28 (24.8) |
 Musculoskeletal complications | 50 (44.2) |
 Hepatopathy | 20 (17.7) |
Quadriceps force | |
 Absolute value (N) | 180 ± 75 |
 Relative value (% to predicted) | 53.8 ± 17.8 |
Handgrip force | |
 Absolute value (kg) | 28.8 ± 11.1 |
 Relative value (% to predicted) | 91.7 ± 30.7 |
 DFRI (/12) | 5.9 ± 3.0 |
 Q1 | 0–3.5 |
 Q2 | 4–6.5 |
 Q3 | 7–8.5 |
 Q4 | 9–12 |
 Tinetti (/12) | 11.0 [5.5; 12.0] |
 Sit-to-Stand (s) | 23.0 [12.0; 50.0] |
 FICSIT (/28) | 15.0 [8.0; 21.0] |
6MWT | |
 Absolute value (m) | 236 [67; 397] |
 Relative value (% to predicted) | 44.1 [12.7; 60.3] |
EQ-5D | |
 Utility score | 0.78 [0.41; 0.90] |
  Reference values based on age/sex | 0.89 ± 0.01 |
 VAS score (max 100) | 58.8 ± 18.9 |
  Reference values based on age/sex | 78.3 ± 23.5 |
PROMIS (T-scores) | |
 Depression | 51.2 ± 9.4 |
 Anxiety | 49.0 ± 9.0 |
 Physical function | 39.7 ± 11.1 |
 Pain interference | 51.1 ± 9.8 |
 Fatigue | 50.6 ± 10.1 |
 Sleep disturbance | 48.1 ± 9.2 |
 Participation in social roles and activities | 48.2 ± 10.0 |